Results 1 to 10 of about 3,469,794 (238)

The clinical case for proton beam therapy [PDF]

Radiation Oncology, 2012
Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing.
Foote Robert L, Stafford Scott L, Petersen Ivy A, Pulido Jose S, Clarke Michelle J, Schild Steven E, Garces Yolanda I, Olivier Kenneth R, Miller Robert C, Haddock Michael G, Yan Elizabeth, Laack Nadia N, Arndt Carola A S, Buskirk Steven J, Miller Vickie L, Brent Christopher R, Kruse Jon J, Ezzell Gary A, Herman Michael G, Gunderson Leonard L, Erlichman Charles, Diasio Robert B   +21 more
doaj   +2 more sources

Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study

Frontiers in Oncology, 2022
BackgroundWe aimed at determining the safety and feasibility of spot-scanning carbon ion radiotherapy (CIRT) for patients with localized prostate cancer.MethodsWe enrolled 118 patients with localized prostate cancer who underwent treatment with spot ...
Ping Li, Ping Li, Ping Li, Zhengshan Hong, Zhengshan Hong, Zhengshan Hong, Yongqiang Li, Yongqiang Li, Yongqiang Li, Shen Fu, Shen Fu, Qing Zhang, Qing Zhang, Qing Zhang   +13 more
doaj   +1 more source

Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers [PDF]

International Journal of Particle Therapy, 2021
Radiotherapy is a common treatment modality in the management of head and neck malignancies. In select clinical scenarios of well-lateralized tumors, radiotherapy can be delivered to the primary tumor or tumor bed and the ipsilateral nodal regions, while
Robert H. Press, MD, Richard L. Bakst, MD, Sonam Sharma, MD, Rafi Kabarriti, MD, Madhur K. Garg, MD, MBA, Brian Yeh, MD, Daphna Y. Gelbum, MD, Shaakir Hasan, DO, J. Isabelle Choi, MD, Chris A. Barker, MD, Arpit M. Chhabra, MD, Charles B. Simone II, MD, FACRO, Nancy Y. Lee, MD, FASTRO   +12 more
doaj   +1 more source

Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net

Clinical and Translational Radiation Oncology, 2023
Background and purpose: To examine the role of proton beam therapy (PBT) in the treatment of extrahepatic biliary tract cancer (EBC). Methods and materials: We analyzed the data accumulated in the Proton-Net database, which prospectively registered all ...
Hideya Yamazaki, Kei Shibuya, Takuya Kimoto, Motohisa Suzuki, Masao Murakami, Kazuki Terashima, Tomoaki Okimoto, Takashi Iizumi, Hideyuki Sakurai, Masaru Wakatsuki, Osamu Suzuki, Norio Katoh, Takeshi Arimura, Takashi Ogino, Masaru Takagi, Masayuki Araya, Takahiro Waki, Sae Matsumoto, Hiroyuki Ogino, Takumi Fukumoto, Masayuki Ohtsuka   +20 more
doaj   +1 more source

Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma [PDF]

International Journal of Particle Therapy, 2023
Purpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in reduced
William M. Mendenhall, MD, Jonathan J. Beitler, MD, MBA, Nabil F. Saba, MD, FACP, Ashok R. Shaha, MD, FACS, Sandra Nuyts, MD, PhD, Primož Strojan, MD, Heleen Bollen, MD, Oded Cohen, MD, Robert Smee, MD, Sweet Ping Ng, MD, Avraham Eisbruch, MD, Wai Tong Ng, MD, Jessica M. Kirwan, MA, Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP   +13 more
doaj   +1 more source

Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study

Radiation Oncology, 2018
Background The usefulness of particle therapy for skull base chordoma has not been established. The aim of this retrospective study was to analyse the treatment outcomes of proton therapy (PT) and carbon ion therapy (CIT) in patients with skull base ...
Masaru Takagi, Yusuke Demizu, Fumiko Nagano, Kazuki Terashima, Osamu Fujii, Dongcun Jin, Masayuki Mima, Yasue Niwa, Kuniaki Katsui, Masaki Suga, Tomohiro Yamashita, Takashi Akagi, Koh-ichi Sakata, Nobukazu Fuwa, Tomoaki Okimoto   +14 more
doaj   +1 more source

Proton beam therapy is a safe and effective treatment in elderly patients with esophageal squamous cell carcinoma

Thoracic Cancer, 2020
Background There are many elderly patients with esophageal squamous cell carcinoma (ESCC). However, there are currently few articles regarding the clinical outcome following proton beam therapy in these patients. The purpose of this study was to evaluate
Takashi Ono, Hitoshi Wada, Hitoshi Ishikawa, Hiroyasu Tamamura, Sunao Tokumaru   +4 more
doaj   +1 more source

Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy

Frontiers in Oncology, 2021
Radiation induced cavernomas among children with medulloblastoma are common following external beam radiation (XRT) treatment with either photon or proton beams.
S. Joy Trybula, Mark W. Youngblood, Hanna R. Kemeny, Jeffrey R. Clark, Constantine L. Karras, William F. Hartsell, William F. Hartsell, Tadanori Tomita   +7 more
doaj   +1 more source

Proton beam therapy for the isolated recurrence of endometrial cancer in para-aortic lymph nodes: a case report

BMC Women's Health, 2022
Background Proton beam therapy penetrates tumor tissues with a highly concentrated dose. It is useful when normal structures are too proximate to the treatment target and, thus, may be damaged by surgery or conventional photon beam therapy.
Kaname Uno, Masato Yoshihara, Sho Tano, Takehiko Takeda, Yasuyuki Kishigami, Hidenori Oguchi   +5 more
doaj   +1 more source

Hybrid Compton-PET imaging for Ion-Range Monitoring in Hadron Therapy [PDF]

EPJ Web of Conferences
Hadron therapy is a rapidly growing cancer treatment, offering high precision in targeting tumors while sparing healthy tissue. However, its full potential is limited by uncertainties in the range of therapeutic ions, largely due to current reliance on X-
Balibrea-Correa J., Babiano-Suarez V., Lerendegui-Marco J., Torres-Sánchez P., Ladarescu I., Pallàs M., Brusasco B., Wulff J., Bäumer C., Rossomme Severine, Warnier Alexis, Tarifeño-Saldivia A., Domingo-Pardo C.   +12 more
doaj   +1 more source